Press Releases
Press Releases
Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine
Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent, Inc., the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health...
Press Releases
DNA Genotek’s ORAcollect RNA kit included in EUA granted to Biocerna SARS-CoV-2 test
DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services and a wholly-owned subsidiary of OraSure Technologies, Inc., announced that its ORAcollect®·RNA kit (OR-100) was included as the collection device for anterior nares (nasal) samples under...
Press Releases
Astellas Efforts Against the Spread of the Coronavirus Disease (COVID-19)
With more and more Americans facing economic hardships as a result of the COVID-19 pandemic, Astellas has implemented changes to its patient assistance programs as part of the company's ongoing commitment to ensuring that patients have access to our...
Packaging & Labelling
United Cargo Meets Growing Demand for Pharmaceuticals with New TempControl Containers
United Cargo announced it will enhance its TempControl service by becoming the first U.S. carrier to lease temperature-controlled shipping containers manufactured by DoKaSch Temperature Solutions.
The new global rental agreement with DoKaSch enables United Cargo's TempControl customers to lease the...
Press Releases
GeoVax and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 Vaccine Development
GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced that Beijing- and Philadelphia-based Sino Biological, Inc. will be its exclusive supplier of SARS-Cov-2 (COVID-19) bioreagent research products.
Under the terms of the...
Press Releases
Quotient Limited Announces CE Mark for its SARS-CoV-2 Antibody Microarray
Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, announced that it has completed the process for declaring conformity to the essential requirements of the In Vitro Diagnostics Directive (IVDD 98/79/EC) and has CE marked (Conformité Européenne) its...
Press Releases
Notable and MDS Foundation Partner on MDS Trials and New Drug Therapies
California-based Notable announced that it has entered a partnership with the MDS Foundation, which is dedicated to providing insight to families on future clinical trials for myelodysplastic syndrome (MDS).
Notable will offer a grant to support the MDS Foundation’s education...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read